At the age of 58 years, these patients showed reduced methylation of the imprinted gene IGF2 (Insulin-like growth factor 2) and a higher risk of obesity or glucose intolerance (Ravelli et al., 1998; Stein et al., 2007). The gene discussed is IGF2; the disease is obesity disorder.